Sign Up for Email Alerts
Kineta Inc.
Kineta Inc.
Kineta Inc.
Close
  • About Us
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean
  • About Us
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • analyst coverage
    • SEC filings
    • corporate governance
    • IRS Form 8937
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean

[be_recent_posts_author_no_link title=”Latest News from Kineta” category_id=”4,3″ num_posts=”6″ post_offset=”0″ num_words_limit=”0″ show_date_author=”1″ show_more_link=”0″ more_link_text=”Read more” show_thumbs=”0″ remove_thumb_frame=”0″ thumb_frame_shadow=”0″ default_thumb=”0″ post_thumb_width=”100″ post_thumb_height=”80″]

Recent Kineta News

  • TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
  • Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024)
  • Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors
  • Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024
  • Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1
Post placeholder image
September 19, 2018 in Biotech Industry News

Venoms to the Rescue

Kineta Inc 2 Like Post Comments Off on Venoms to the Rescue
Read More
Post placeholder image
September 11, 2018 in Biotech Industry News

Immuno-oncology “Set to Become the Fifth Pillar of Cancer Treatment”

Kineta Inc 2 Like Post Comments Off on Immuno-oncology “Set to Become the Fifth Pillar of Cancer Treatment”
Read More
Post placeholder image
September 5, 2018 in Kineta Press Release

Kineta Initiates First-in-Human Clinical Trial of LHF-535 a Novel Therapy for Lassa Fever

Kineta Inc 4 Like Post Comments Off on Kineta Initiates First-in-Human Clinical Trial of LHF-535 a Novel Therapy for Lassa Fever

Kineta Initiates First-in-Human Clinical Trial of LHF-535 a Novel Therapy for Lassa Fever Phase 1 study to assess the safety, tolerability and pharmacokinetic profile of LHF-535 in healthy volunteers ...

Read More
Post placeholder image
August 28, 2018 in Biotech Industry News

Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act

Kineta Inc 1 Like Post Comments Off on Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
Read More
Post placeholder image
August 23, 2018 in Biotech Industry News

FDA Adds 4 Diseases to Tropical Diseases Priority Review Voucher Program

Kineta Inc 1 Like Post Comments Off on FDA Adds 4 Diseases to Tropical Diseases Priority Review Voucher Program
Read More
Post placeholder image
August 23, 2018 in Biotech Industry News

Lassa fever, chikungunya, rabies, and cryptococcal meningitis added to FDA tropical diseases list

Kineta Inc 1 Like Post Comments Off on Lassa fever, chikungunya, rabies, and cryptococcal meningitis added to FDA tropical diseases list
Read More
Post placeholder image
June 29, 2018 in Biotech Industry News

Increased Development of Non-Opioid Pain Treatments is Expected to Continue

Kineta Inc 1 Like Post Comments Off on Increased Development of Non-Opioid Pain Treatments is Expected to Continue
Read More
Post placeholder image
May 7, 2018 in Biotech Industry News

Drug Makers Developing Non-Opioid Pain Alternatives to Battle the Opioid Epidemic

Kineta Inc 1 Like Post Comments Off on Drug Makers Developing Non-Opioid Pain Alternatives to Battle the Opioid Epidemic
Read More
Post placeholder image
April 30, 2018 in Biotech Industry News

Kineta Developing Non-Opioid Pain Drug That Does More Than Just “Mask” the Problem

Kineta Inc 1 Like Post Comments Off on Kineta Developing Non-Opioid Pain Drug That Does More Than Just “Mask” the Problem
Read More
Post placeholder image
April 16, 2018 in Biotech Industry News

Kineta starts drug development collaboration with Genentech

Kineta Inc 4 Like Post Comments Off on Kineta starts drug development collaboration with Genentech
Read More
Prev12345Next

219 Terry Ave. N. Suite 300. Seattle, WA 98109

Sign Up for Email Alerts

219 Terry Ave. N. Suite 300. Seattle, WA 98109

  • About Us
  • pipeline
  • partnerships
  • investors
  • contact
Sign Up for Email Alerts

© 2025 Kineta Inc.        Privacy Policy       Terms of Use

English
English
Korean